These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 16750691)

  • 1. Utility of impedance cardiography for the identification of short-term risk of clinical decompensation in stable patients with chronic heart failure.
    Packer M; Abraham WT; Mehra MR; Yancy CW; Lawless CE; Mitchell JE; Smart FW; Bijou R; O'Connor CM; Massie BM; Pina IL; Greenberg BH; Young JB; Fishbein DP; Hauptman PJ; Bourge RC; Strobeck JE; Murali S; Schocken D; Teerlink JR; Levy WC; Trupp RJ; Silver MA;
    J Am Coll Cardiol; 2006 Jun; 47(11):2245-52. PubMed ID: 16750691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous monitoring of intrathoracic impedance and right ventricular pressures in patients with heart failure.
    Vanderheyden M; Houben R; Verstreken S; Ståhlberg M; Reiters P; Kessels R; Braunschweig F
    Circ Heart Fail; 2010 May; 3(3):370-7. PubMed ID: 20197559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic utility of B-type natriuretic peptide assessment in stable low-risk outpatients with nonischemic cardiomyopathy after decompensated heart failure.
    Nishii M; Inomata T; Takehana H; Naruke T; Yanagisawa T; Moriguchi M; Takeda S; Izumi T
    J Am Coll Cardiol; 2008 Jun; 51(24):2329-35. PubMed ID: 18549918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrathoracic impedance and pulmonary wedge pressure for the detection of heart failure deterioration.
    Maines M; Catanzariti D; Cirrincione C; Valsecchi S; Comisso J; Vergara G
    Europace; 2010 May; 12(5):680-5. PubMed ID: 20047927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impedance cardiography: a potential monitor for hemodialysis.
    Wynne JL; Ovadje LO; Akridge CM; Sheppard SW; Vogel RL; Van de Water JM
    J Surg Res; 2006 Jun; 133(1):55-60. PubMed ID: 16631198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in intrathoracic impedance are associated with subsequent risk of hospitalizations for acute decompensated heart failure: clinical utility of implanted device monitoring without a patient alert.
    Small RS; Wickemeyer W; Germany R; Hoppe B; Andrulli J; Brady PA; Labeau M; Koehler J; Sarkar S; Hettrick DA; Tang WH
    J Card Fail; 2009 Aug; 15(6):475-81. PubMed ID: 19643357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Munich score: a clinical index to predict survival in ambulatory patients with chronic heart failure in the era of new medical therapies.
    Stempfle HU; Alt A; Stief J; Siebert U
    J Heart Lung Transplant; 2008 Feb; 27(2):222-8. PubMed ID: 18267231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and prognostic value of Duke's Activity Status Index along with plasma B-type natriuretic peptide levels in chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Parissis JT; Nikolaou M; Birmpa D; Farmakis D; Paraskevaidis I; Bistola V; Katsoulas T; Filippatos G; Kremastinos DT
    Am J Cardiol; 2009 Jan; 103(1):73-5. PubMed ID: 19101233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring intrathoracic impedance with an implantable defibrillator reduces hospitalizations in patients with heart failure.
    Catanzariti D; Lunati M; Landolina M; Zanotto G; Lonardi G; Iacopino S; Oliva F; Perego GB; Varbaro A; Denaro A; Valsecchi S; Vergara G;
    Pacing Clin Electrophysiol; 2009 Mar; 32(3):363-70. PubMed ID: 19272067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systolic blood pressure does not reliably identify vasoactive status in chronic heart failure.
    Parrott CW; Quale C; Lewis DL; Ferguson S; Brunt R; Glass S
    Am J Hypertens; 2005 Feb; 18(2 Pt 2):82S-86S. PubMed ID: 15752937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rationale and design of a prospective trial to assess the sensitivity and positive predictive value of implantable intrathoracic impedance monitoring in the prediction of heart failure hospitalizations: the SENSE-HF study.
    Cowie MR; Conraads V; Tavazzi L; Yu CM;
    J Card Fail; 2009 Jun; 15(5):394-400. PubMed ID: 19477399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).
    O'Connor CM; Abraham WT; Albert NM; Clare R; Gattis Stough W; Gheorghiade M; Greenberg BH; Yancy CW; Young JB; Fonarow GC
    Am Heart J; 2008 Oct; 156(4):662-73. PubMed ID: 18926148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is haemodynamic evaluation with impedance cardiography in patients with heart failure undergoing testing of the implanted cardioverter-defibrillator of clinical importance?
    Krzesiński P; Michałkiewicz D; Orski Z; Krzyżanowski K; Gielerak G
    Kardiol Pol; 2011; 69(6):548-56. PubMed ID: 21678288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracardiac impedance monitors hemodynamic deterioration in a chronic heart failure pig model.
    Stahl C; Beierlein W; Walker T; Straub A; Nagy Z; Knubben K; Greiner TO; Lippert M; Czygan G; Paule S; Schweika O; Kühlkamp V
    J Cardiovasc Electrophysiol; 2007 Sep; 18(9):985-90. PubMed ID: 17553076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical utility of intrathoracic impedance monitoring to alert patients with an implanted device of deteriorating chronic heart failure.
    Vollmann D; Nägele H; Schauerte P; Wiegand U; Butter C; Zanotto G; Quesada A; Guthmann A; Hill MR; Lamp B;
    Eur Heart J; 2007 Aug; 28(15):1835-40. PubMed ID: 17309902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrathoracic impedance monitoring to predict decompensated heart failure.
    Ypenburg C; Bax JJ; van der Wall EE; Schalij MJ; van Erven L
    Am J Cardiol; 2007 Feb; 99(4):554-7. PubMed ID: 17293202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved algorithm to detect fluid accumulation via intrathoracic impedance monitoring in heart failure patients with implantable devices.
    Sarkar S; Hettrick DA; Koehler J; Rogers T; Grinberg Y; Yu CM; Abraham WT; Small R; Tang WH
    J Card Fail; 2011 Jul; 17(7):569-76. PubMed ID: 21703529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The utility of microvascular perfusion assessment in heart failure: a pilot study.
    Hogan CJ; Hess ML; Ward KR; Gennings C
    J Card Fail; 2005 Dec; 11(9):713-9. PubMed ID: 16360968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of paroxysmal atrial tachyarrhythmias to volume overload: assessment by implanted transpulmonary impedance monitoring.
    Jhanjee R; Templeton GA; Sattiraju S; Nguyen J; Sakaguchi S; Lu F; Ermis C; Milstein S; Van Heel L; Lurie KG; Benditt DG
    Circ Arrhythm Electrophysiol; 2009 Oct; 2(5):488-94. PubMed ID: 19843916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk stratification of mortality in patients with heart failure and left ventricular ejection fraction >35%.
    Cygankiewicz I; Zareba W; Vazquez R; Bayes-Genis A; Pascual D; Macaya C; Almendral J; Fiol M; Bardaji A; Gonzalez-Juanatey JR; Nieto V; Valdes M; Cinca J; de Luna AB;
    Am J Cardiol; 2009 Apr; 103(7):1003-10. PubMed ID: 19327431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.